
Susan has worked in the pharmaceutical and CRO industry for over 11 years in
medium-sized and small biotech companies including a virtual pharmaceutical
company specializing in developing treatments for psychiatric and neurological
disorders where she gained an in-depth knowledge of drug development.
Susan has valuable experience in attending meetings and presenting data
at the FDA and EMEA, filing a New Drug Application with the EMEA, and
designing and obtaining agreement on the overall development requirements
for a lead Phase III compound with the FDA. Susan also has a wealth of
knowledge in financial management, intellectual property management as
well as legal and contractual issues specific to the pharmaceutical and
CRO industries.
Susan is a member of the Institute of Chartered Accountants of Scotland
and qualified with Ernst & Young. She has an honours degree in Accountancy
from Stirling University. Susan is a member of the Institute of Clinical
Research.

Fiona has over 16 years’ experience, within the pharmaceutical and CRO industry working for
large companies, then medium sized/small biotech companies.
Her experience spans Phase I to Phase III, in North America and in Europe.
She has worked in psychiatry and neurology for the last eight years.
After a solid grounding in Clinical Research as CRA and then project
manager, Fiona moved on to set up and direct a clinical operation and
a project management team, with responsibility for overseeing all clinical
trials as well as for CRO selection/management, Regulatory Affairs, Medical
Writing, QA and SOPs. Fiona was a key member of high level management
teams including those with responsibility for strategic development of
a lead Phase III compound and submissions for marketing approval.
Fiona has an honours degree in Biochemistry/Immunology from Strathclyde
University and a Post-Graduate Diploma in Information Technology and
is a member of the Institute of Clinical Research.

Mark has 22 years experience within the pharmaceutical, CRO and medical device industries. His experience spans Phase I to Phase IV clinical studies and Mark has managed multinational clinical trial projects for pharmaceutical and biotech companies and for CRO’s. Mark’s responsibilities have included overseeing clinical trial programs, budgets and contract negotiations and his therapeutic experience covers CNS, oncology, gastroenterology, cardiovascular, endocrinology, genitourinary, musculoskeletal, respiratory disease, and anaesthesia.
Mark has a B.Sc. (Biology Major) from Stirling University and is a member of the Institute of Clinical Research.

Crispin has over 11 years' experience in the pharmaceutical
industry in medium-sized and small biotech companies including a virtual
pharmaceutical company specializing in developing drugs for CNS disorders
where he gained an in-depth knowledge of CNS drug development. By working
alongside Dr David Horrobin, an internationally renowned medical researcher
and entrepreneur, he gained a wealth of knowledge on lipids and fatty
acids. In addition, he has worked in top-level project and management
teams developing key products, authored and contributed to a range of
documents including peer reviewed published papers where his subject
knowledge and ability to describe complex ideas in a clear, incisive
manner were of major benefit. He has also worked on submissions for product
marketing approval to the European and US regulatory authorities and
has considerable experience of supplying scientific and business information
to colleagues and research scientists.
Crispin has an honours degree in Animal Sciences from Reading University
and has a PhD in Dairy Science from Glasgow University.

Amanda has over 11 years’ professional administrative experience at a senior
level within the pharmaceutical and CRO industry and has invaluable experience in
administering extensive, complex patent portfolios. She was also the
Editorial Assistant for two peer review journals and Assistant Company
Secretary for a small pharmaceutical company.
Amanda is an Associate (ACIS) of the Institute of Chartered Secretaries and Administrators (ICSA) and has an MSc in Administrative and Information Management from Napier University and a Bachelor of Arts from Stirling University.

Lesley has 10 years clinical research experience within the pharmaceutical and CRO industry, at CRA and at Project Management level.
Lesley has experience in co-ordinating clinical trial activities from study set-up through to clinical study report for European and US clinical trials. Lesley started her career in Research and Development as a Molecular Biologist with Glaxo Welcome. She moved on to become a Clinical Research Scientist with Glaxo Welcome and then joined Chiltern International as a CRA covering all monitoring duties within a large heart/stroke endpoints study. Since 2001 Lesley has worked in CNS/Psychiatry as senior CRA then Clinical Project Manager for an emerging Pharmaceutical Company working on studies in depression and Huntington's disease.
Lesley has a background in Biochemistry (Bacterial Genetics, Dundee University) and a Post-graduate Diploma in Biotechnology. Lesley is a member of the Institute of Clinical Research.

Laura has 5 years clinical research experience within the pharmaceutical and CRO industry at CTA level.
Laura has a degree in Biology (BSc. Hon. Stirling University) and is a member of the Institute of Clinical Research.

Jo has 3 years experience within the pharmaceutical and CRO industry at CRA level.
Jo has a degree in Biomedical Science (BSc. Hon. Liverpool John Moores University) and has a Ph.D. in generation and characterisation of monoclonal antibodies against bone-specific alkaline phosphatases from Liverpool University. Jo is a member of the Institute of Clinical Research.

Jean-Louis has studied Clinical Research for 1 year and has experience of working as a Clinical Research Associate. Jean-Louis has a degree in Biology (Diplôme Universitaire de Technologie = University Degree in Technology, equivalent to an HND) from Brest University, and two degrees in Biological Imaging and Neurosciences (Maîtrise des Sciences et Techniques = Master in Sciences and Techniques, equivalent to a BSc Hons + Diplôme d'Etudes Supérieures Spécialisées = Degree in Specialized Superior Education, equivalent to an MSc) from Caen and Strasburg Universities.
Jean-Louis has relocated from Paris to join QCTR. He is fluent in French, Spanish and English and is a member of the Institute of Clinical Research.

Sabine has over a years experience working as a Clinical Research Associate in Phase III and IIIb clinical studies. Sabine is a State Certified Nurse (Germany) and also has a Degree in Cultural Studies and English Literature Studies (MA).
Sabine has relocated from Germany to join QCTR. She is fluent in German, her native language, as well as in English. Sabine is a member of the Institute of Clinical Research.

Debbie has 5 years experience in Clinical Research working first as a Clinical Research Associate and then as Clinical Team Lead and Country Research Manager. Debbie set up and ran the Maltese Office of a large CRO and was the European Regional Team Lead for 8 countries. Debbie has worked on Phase II and III clinical studies in a number of indications.
Debbie has an Honours Degree in Communication from the University of Malta and a Diploma in Anatomy and Physiology from Oxford University. Debbie is fluent in Maltese, English and Italian. Debbie has re-located from Malta to join the QCTR team. Debbie is a member of the Institute of Clinical Research.
VAT Number 880 3892 93 || Company Registration Number: 289921
© 2006 QCTR Ltd. || Web
Design by Farmore IT Ltd.